NOMAD POWER SOLUTIONS INC

NMADNASDAQ

🏆 #3462 by market capUS Equity

$3.56▼ $0.33 (−9.41%)

🌙 After hours$3.74▲ 5.12%Regular close · extended-hours price shown

1h—

24h▼ 9.4%

7d▼ 7.8%

14d▼ 11.0%

30d▼ 38.1%

1y▼ 25.8%

🏦Market Cap

$44M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

Trading Snapshot

Day Range: $3.53 – $3.59
52-Week Range: $2.36 – $8.38
Volume: $2.00B
Avg Volume: $1.35B
Shares Outstanding: 12.4M
Next Earnings: Sep 25, 2026

Fundamentals Snapshot

Annual Revenue: $14M
Last Q Revenue: $3M
P/E Ratio: —
P/S Ratio: —
EPS (TTM): —
Dividend Yield: —

Why Investors Own NMAD

✓High-growth profile — revenue up +53.7% YoY with expanding US Equity exposure.
✓Healthy economics — 79% gross margin and 16% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$14M▲ +54.7% YoY

Gross Margin (TTM)

78.8%▲ +2.8% YoY

Operating Income (TTM)

$2M▲ +54.7% YoY

Free Cash Flow (TTM)

$2M▲ +54.7% YoY

About NOMAD POWER SOLUTIONS INC

Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Boca Raton, FL.

🦦